Osaic Holdings’s Athira Pharma ATHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.5K Buy
63,500
+36,000
+131% +$21.2K ﹤0.01% 4897
2025
Q1
$7.7K Sell
27,500
-36,000
-57% -$10.1K ﹤0.01% 5860
2024
Q4
$37.5K Sell
63,500
-18,850
-23% -$11.1K ﹤0.01% 4881
2024
Q3
$37.1K Buy
82,350
+52,300
+174% +$23.5K ﹤0.01% 4929
2024
Q2
$79.6K Sell
30,050
-133,539
-82% -$354K ﹤0.01% 4297
2024
Q1
$448K Sell
163,589
-6,416
-4% -$17.6K ﹤0.01% 3032
2023
Q4
$413K Buy
170,005
+27,936
+20% +$67.9K ﹤0.01% 3320
2023
Q3
$287K Sell
142,069
-4,900
-3% -$9.9K ﹤0.01% 3724
2023
Q2
$434K Buy
146,969
+9,800
+7% +$28.9K ﹤0.01% 3264
2023
Q1
$343K Sell
137,169
-9,400
-6% -$23.5K ﹤0.01% 3429
2022
Q4
$464K Buy
146,569
+10,550
+8% +$33.4K ﹤0.01% 3094
2022
Q3
$404K Buy
136,019
+1,000
+0.7% +$2.97K ﹤0.01% 3096
2022
Q2
$412K Buy
135,019
+500
+0.4% +$1.53K ﹤0.01% 3121
2022
Q1
$1.82M Sell
134,519
-600
-0.4% -$8.1K ﹤0.01% 2003
2021
Q4
$1.76M Buy
135,119
+4,225
+3% +$55.1K ﹤0.01% 1888
2021
Q3
$1.23M Sell
130,894
-100
-0.1% -$937 ﹤0.01% 2153
2021
Q2
$1.34M Buy
130,994
+115,814
+763% +$1.19M ﹤0.01% 2077
2021
Q1
$279K Buy
15,180
+800
+6% +$14.7K ﹤0.01% 3451
2020
Q4
$493K Buy
14,380
+14,280
+14,280% +$490K ﹤0.01% 2646
2020
Q3
$2K Buy
+100
New +$2K ﹤0.01% 5750